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CLINICAL CASE

SUPERIOR VENA CAVA SYNDROME DUE TO CENTRAL
VENOUS CATHETER THROMBOSIS: CLINICAL CASE
SINDROME DE VENA CAVA SUPERIOR POR TROMBOSIS DE CATETER VENOSO
CENTRAL: CASO CLINICO
Marco Antonio Vergara Labrín1,a, Miguel Angel Guevara Cruz1,a,b, Hernán Aste Salazar1,a,c,
Aurelio Napoleón Delgado Salazar1,d,e

ABSTRACT

CLINICAL CASE

Introduction: Superior vena cava syndrome is a rare entity in literature. Clinical Case: We present the case of
a 32-year-old male patient who visited the Emergency Department due to sudden facial cyanosis, facial
pressure, dry cough, odynophagia, and dysphonia, without reporting dyspnea. On physical examination:
face, neck, and supraclavicular region edema, central cyanosis, petechiae, and subungual haemorrhage in
the hands. History of colon neoplasia, with colostomy and placement of a left subclavian Port catheter two
years ago. CT angiography shows a lling defect due to recent thrombosis in the internal jugular veins, left
and right brachiocephalic veins, arch of the azygos, and superior vena cava in all its lumen. Neoplastic
pathology associated with invasive procedures with central venous catheters increases the risk of
presentation, as in our case, with severe intrinsic complete venous obstruction. Surgical treatment with
thrombectomy by mechanical aspiration allowed total resection of the thrombus and full restoration of
circulation.
Keywords: Superior vena cava syndrome; Central venous catheters; Thrombosis, Thrombectomy, Case
report. (Source: MeSH NLM)

RESUMEN
Introducción: El síndrome de vena cava superior es una entidad poco frecuente en la literatura. Caso Clínico:
Presentamos el caso de paciente masculino, 32 años, que consulta al servicio de emergencia por cianosis
facial súbita, opresión en rostro, tos seca, odinofagia, disfonía; sin referir disnea. Al examen físico: edema en
esclavina, cianosis central, petequias y sangrado ungueal en manos. Antecedente de neoplasia de colón, con
colostomía y colocación de catéter Port subclavio izquierdo hace dos años. La angiotomogra a muestra
defecto de llenado por trombosis reciente en venas yugular interna, braquiocefálica izquierda y derecha, arco
de la ácigos y cava superior en toda su luz. La patología neoplásica asociada a procedimientos invasivos con
catéter venosos centrales elevan el riesgo de presentación, como nuestro caso, con una obstrucción venosa
completa intrínseca severa. El tratamiento quirúrgico con trombectomía por aspiración mecánica permitió la
resección total del trombo y restitución integral de la circulación.
Palabras clave: Síndrome de la vena cava superior; Catéteres venosos centrales; Trombosis; Trombectomía,
Reporte de caso. (Fuente: DeCS BIREME).
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INTRODUCTION

CLINICAL CASE

Superior vena cava syndrome (SVCS) is an entity rarely
described (1) since the rst report by Hunter in 1 757 (2); it
is de ned as a group of symptoms and signs caused by
the complete or partial obstruction of blood ow from
the superior vena cava (SVC) to the right atrium (RA),
producing a retrograde increase in venous pressure in
the head, neck and upper extremities.
Previously, the main cause of this syndrome was
infectious diseases, such as syphilitic aneurysms and
tuberculous mediastinitis, but currently, lung
neoplasms and lymphomas are the most frequently
involved(3); some cases of benign causes have also been
reported, such as thrombosis, associated with the
increased use of central venous catheters (CVC)(4), postradiotherapy mediastinitis, intrathoracic goiter, thymus
or thyroid tumors, and venous infections, which are
published in a scattered and isolated way.
In our case, it was caused by a thrombotic invasion of its
lumen, in a patient with a signi cant history of colon
cancer and the placement of a permanent central
venous catheter two years ago, an association that
increases the risk of presentation.
The clinical examination is characterized by the classic
triad of face, neck, and supraclavicular region edema,
cyanosis of the face, and thoracobrachial collateral
circulation. Imaging techniques such as chest CT scan
are used for de nitive diagnosis (5).
The therapeutic plan will be based fundamentally on
the restoration of blood ow. In our patient, surgery
accomplished complete resection of the thrombus and
total restitution of venous circulation, with relative
safety and low mortality prognosis (6).

DESCRIPTION OF THE CLINICAL
CASE
A 32-year-old male patient presented to the Emergency
Department of the SANNA San Borja Clinic in Lima due
to sudden onset of facial cyanosis, facial pressure that
increased with standing, and a feeling of imminent
fainting. Dry cough, odynophagia, dysphonia,
subjective dizziness; without referring dyspnea,
hemoptysis, or feeling febrile.
Pathological History: denies drug allergy, colon
neoplasia since July 2019 with left colostomy and left
subclavian Port catheter placement, currently in
recurrence with 20 chemotherapy sessions, FOLFIRI
regimen (leucovorin calcium or folinic acid, veuorouracil and irinotecan hydrochloride) plus
panitumumab that ended three days before.
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He was admitted with BP 116/65 mmHg, HR 120x´, RR
24x´, T 36°C, and SatO2 97%. On physical exam: facial
plethora, edema of both lips, face, and neck, central
cyanosis, multiple petechiae in the anterior chest and
upper limbs, spontaneous subungual haemorrhage on
both hands. R1 and R2 are normophonetic, rhythmic,
without murmurs, vesicular breath sounds present
without additional noises, tachypnea, and poor
tolerance to decubitus. Soft, painless abdomen, bowel
sounds (+), left colostomy. He is alert, oriented in time
and space, and without focal neurologic de cits.
Laboratory: Hb 13,4g/dL, WBC 7,670/ul, platelets
195,000/ul, prothrombin time 10,7 seconds, INR 0,90,
partial thromboplastin time 17,8 seconds, D-dimer 4,81
(RI 0,01-0,50ug FEU/ml), urea 51mg/dl, creatinine
0,85mg/dl, pH 7,46, pO2 85,8mmHg, pCO2 27,9mmHg,
HCO3 19,6mmol/L, SatO2 96,9%. Upper extremity
venous Ultrasound Doppler shows the presence of
small masses that obstruct SVC drainage and left
innominate, mild dilation with no inspiratory collapse.
Neck and chest CT angiography show a lumen lling
defect in the distal left internal jugular veins
(longitudinal extension 66 mm), left brachiocephalic in
full extension (57 mm), right brachiocephalic distal
portion (21.4 mm), arch of the azygos (25.3 mm), and
SVC in all its lumen (67 mm), due to recent thrombosis,
type IV - severity C (5). Multiple mediastinal venous
collaterals. In the left subclavian vein, periphlebitic
edematous changes with foci of subcutaneous
emphysema which are signs suggestive of
thrombophlebitis. Small subendocardial thrombus in
the RA operculum. No signs of pulmonar y
hypertension. Figure 1.
Anticoagulation with subcutaneous enoxaparin 80mg
every 12 hours and antibiotic therapy with vancomycin
plus piperacillin-tazobactam is started immediately,
and he is hospitalized. On the fth day of admission,
surgical intervention was decided to per form
mechanical thromboaspiration. A temporar y
Capturex®-type lter was placed by a right femoral
puncture at the outlet of the SVC with the RA, a lter that
opens like an umbrella and protects against possible
pulmonar y embolisms during the aspiration
procedure. A Rotarex® aspiration catheter was
introduced, with head rotation, because waiting for the
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is achieved Figures 2 and 3. At the outlet of the SVC,
there was a segment that was not completely cleaned,
dilation was performed with 2 10mm “kissing balloons”,
obtaining adequate contrast ow. Finally, the lter was
aspirated and the left Port catheter, suspected of
causing initial thrombophlebitis, was removed and sent
for culture.
The patient evolves with a notable decrease in facial
and UE edema in the following 36 hours, with no facial
redness. Oral anticoagulation is started at hospital
discharge and later follow-up by outpatient clinic.

DISCUSSION
SVCS is a rare entity, it has an approximate incidence of

1.500 patients/year in Argentina and 15.000
patients/year in the United States of America, but the
true numbers are not well described in the literature
since only case series published in the scattered and
isolated form are found (1).
The causes are classi ed into benign and malignant.
Currently, 15 to 40% have their origin in thrombosis and
benign diseases(2), the consequence of the increased
use of endovascular devices, such as CVCs is 4% and
pacemakers and cardioverter de brillators is 13.9%(4).
Also, take into account post-radiotherapy mediastinitis
and venous infections. Among the malignant causes,
lung cancer and lymphoma account for up to 90% of
cases (3). Table 1.

Malignant Causes

CLINICAL CASE

Table 1. Causes of superior vena cava syndrome (SVCS)

(3)

.

Benign Causes

Lung carcinoma. (75%)
- Small cell.
- Non-small cell.

Thrombosis due to endovascular devices (reservoir
catheter, for dialysis, pacemaker cables, venousperitoneal shunts). (4-14%)

Lymphoma:
- Non-Hodgkin. (10 – 12%)
- Hodgkin's disease. (rare)

Mediastinal brosis:
- brosing mediastinitis.
- post-radiotherapy.

Mediastinal or paratracheal lymph node
metastases from other tumors. (9%)
- breast carcinoma.
- germ cell tumor.
- esophageal cancer.

Vasculitis: Behcet's disease, due to increased
thrombogenic risk associated with vascular wall
in ammation. Paroxysmal nocturnal hemoglobinuria.
Thrombophlebitis.

Others:
- thyroid carcinoma.
- invasive thymoma.

Others: - endothoracic goiter.
- aortic or subclavian aneurysm.
- sarcoidosis.

Another categorization denominates the idiopathic
form that’s related to eﬀorts (Paget-Schroetter
syndrome), and the thoracic outlet syndrome as
primary; the secondary causes, which represent 80% of
the cases, include neoplasms, intravenous devices, and
thrombophilias, such as protein C de ciency, protein S
de ciency, antithrombin III de ciency or factor V Leiden
and prothrombin G20210A heterozygotes (7).
Depending on the location of the obstruction, SVCS
may be due to intrinsic causes, with venous thrombosis
being the most frequent, or extrinsic, to any mass
located in the middle or anterior mediastinum,
predominantly on the right (8).

The severity of this syndrome depends on the
evolution, degree, and level of the obstruction, which
generates a decrease in venous return from the upper
half of the body towards the RA, retrograde stasis
increases venous pressure in the head, neck, and upper
extremities (UE) that usually reach 20 - 40 mmHg
(normal two to eight mmHg), causing dilation of
collateral veins to increase venous capacitance(6); when
this mechanism fails, it determines the appearance of
symptoms and the classic triad on physical examination
of the face, neck, and supraclavicular region edema.
There is also central cyanosis, and thoracobrachial
collateral circulation.
Clinical manifestations appear gradually starting the
second week of compression of the SVC, in 33% of cases,
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it usually goes unnoticed (9,10).

CLINICAL CASE

Neoplasia, in the case of our patient, aﬀecting the colon,
is the most important risk factor for SVC thrombosis.
Nevertheless, the spontaneous appearance of the
thrombus is infrequent if it is not associated with an
endovascular device, radiation therapy, or extrinsic
tumor compression(11). The presence of CVC is the most
outstanding independent predictor for the appearance
of thrombosis; in the SVC system, they occur in 55% of
patients who have or have had a central access placed in
the past 30 days. The association between CVC infection
and clot formation is well established, the relative risk is
increased 17-fold, compared to those without catheter
infection(12).
For the ultrasound diagnosis, the patency and
competence of the veins must be demonstrated;
compression is probably the most important maneuver
since thrombosed veins do not collapse despite
external pressure. The use of color Doppler is crucial to
evaluate central veins that cannot be compressed and
facilitates the visualization of stenosis and the
secondary collateral venous network, with sensitivity
between 82 and 97% and speci city between 82 and
96%(13).
Multislice chest CT scan without or with contrast is
nowadays the study of choice and the most used; in
addition to con rming the diagnosis, it allows assessing
the level and severity of the obstruction, with sensitivity
and speci city of 96 and 92% respectively (14).
In the treatment, maintain the head at 45º, administer
oxygen and reduce cardiac preload with loop diuretics.
Steroid use is useful in suspected cerebral or airway
edema, or both (8). Most of the scienti c evidence results
from case series because there are very few randomized
studies, so de nitive management is not established. In
acute thrombosis (symptoms less than 2 days),
thrombolytic therapy followed by anticoagulants is the
most recommended(15), and in most cases, it allows to
maintain the catheter (7). On the contrary, it is less
eﬀective in chronic thrombosis (evolution greater than
10 days).
Authorship contributions: The authors declare that
we have read and approved the manuscript and the
authorship requirements have been met.

Regarding invasive strategies, angioplasty with the
placement of an intravascular self-expanding
prosthesis is eﬀective and oﬀers rapid relief of
symptoms(16), cyanosis improves in a few hours and
edema in 72 hours, 75 to 100% of cases, and can still be
performed without an etiological diagnosis, especially
in severe cases. However, in other prospective series,
symptoms resolved in only 17% (17). Complications of
stent placement are 3% to 7% and include infection,
pulmonary embolism, device migration, insertion site
hematoma, and, very rarely, perforation (9,18).
Nowadays, surgical treatment contain clot aspiration
systems that reduce the need to leave devices in the
venous lumen, reducing the probability of subsequent
complications. This technique is relatively safe and has
low mortality in expert hands(6), being the rst resource
in other institutions where interventional radiology is
not available. The best results are obtained within the
rst 14 days after the thrombosis occurs, decreasing
eﬃcacy in prolonged evolutions, where stent
placement is sometimes necessary. In our case, surgery
also allowed the removal of the Port reservoir catheter,
considering that its maintenance signi cantly
increased the risk of new thrombosis, in addition to
being considered an infectious focus(19).
To conclude, we can say that the diagnosis of SVCS is
primarily clinical, hence the importance of suspicion
starting from the Emergency Department, which can
be con rmed with a simple complementary exam such
as computed tomography angiography. Most cases are
due to malignant diseases; therefore, therapeutic
planning must be multidisciplinary. In patients with
severe symptoms or signs of obstruction, surgery
allows resection of the thrombus and restoration of
circulation, with relative safety and low mortality. In our
case, it also allowed removing the central venous
reservoir catheter.
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